Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabrice André

Showing results (1-10 of 245) with videos related to

Pageof 25
Sort By:
Breast Cancer Research and Treatment|February 14, 2015
Rationale for targeting fibroblast growth factor receptor signaling in breast cancerFabrice André, Javier Cortés
Bulletin Du Cancer|June 21, 2011
[Her2 a paradigm for targeted therapy]Hélène Marijon, Fabrice André
La Revue Du Praticien|March 4, 2014
[Supervision after breast cancer treatment]Shanna Rajpar, Fabrice André
Cancers|April 30, 2021
Tribbles Pseudokinase 3 Regulation and Contribution to CancerBojana Stefanovska, Fabrice André, Olivia Fromigué
Nature Reviews. Clinical Oncology|June 17, 2010
Molecular circuits of solid tumors: prognostic and predictive tools for bedside useCharles Ferté, Fabrice André, Jean-Charles Soria
Breast (Edinburgh, Scotland)|August 5, 2015
What to expect from high throughput genomics in metastatic breast cancers?Concetta Elisa Onesti, Cécile Vicier, Fabrice André
BMC Medicine|June 11, 2015
Targeted therapies for ER+/HER2- metastatic breast cancerMutsuko Yamamoto-Ibusuki, Monica Arnedos, Fabrice André
Expert Opinion on Biological Therapy|June 15, 2005
The potential of exosomes in immunotherapyNathalie Chaput, Julien Taïeb, Fabrice André, et al.
Critical Reviews in Oncology/Hematology|August 6, 2010
Resistance to HER2 inhibitors: is addition better than substitution? Rationale for the hypothetical concept of drug sedimentationMario Campone, Philippe Juin, Fabrice André, et al.
Current Opinion in Genetics & Development|March 4, 2014
Genomes in the clinic: the Gustave Roussy Cancer Center experienceLudovic Lacroix, Amelie Boichard, Fabrice André, et al.
Pageof 25

Showing results (1-10 of 245) with videos related to

Sort By:
Pageof 25
Breast Cancer Research and Treatment|February 14, 2015
Rationale for targeting fibroblast growth factor receptor signaling in breast cancerFabrice André, Javier Cortés
Bulletin Du Cancer|June 21, 2011
[Her2 a paradigm for targeted therapy]Hélène Marijon, Fabrice André
La Revue Du Praticien|March 4, 2014
[Supervision after breast cancer treatment]Shanna Rajpar, Fabrice André
Cancers|April 30, 2021
Tribbles Pseudokinase 3 Regulation and Contribution to CancerBojana Stefanovska, Fabrice André, Olivia Fromigué
Nature Reviews. Clinical Oncology|June 17, 2010
Molecular circuits of solid tumors: prognostic and predictive tools for bedside useCharles Ferté, Fabrice André, Jean-Charles Soria
Breast (Edinburgh, Scotland)|August 5, 2015
What to expect from high throughput genomics in metastatic breast cancers?Concetta Elisa Onesti, Cécile Vicier, Fabrice André
BMC Medicine|June 11, 2015
Targeted therapies for ER+/HER2- metastatic breast cancerMutsuko Yamamoto-Ibusuki, Monica Arnedos, Fabrice André
Expert Opinion on Biological Therapy|June 15, 2005
The potential of exosomes in immunotherapyNathalie Chaput, Julien Taïeb, Fabrice André, et al.
Critical Reviews in Oncology/Hematology|August 6, 2010
Resistance to HER2 inhibitors: is addition better than substitution? Rationale for the hypothetical concept of drug sedimentationMario Campone, Philippe Juin, Fabrice André, et al.
Current Opinion in Genetics & Development|March 4, 2014
Genomes in the clinic: the Gustave Roussy Cancer Center experienceLudovic Lacroix, Amelie Boichard, Fabrice André, et al.
Pageof 25